Innoviva, Inc. (INVA)
Innoviva has a market cap or net worth of $893.37 million. The enterprise value is $1.14 billion.
The last earnings date was Wednesday, November 1, 2023, after market close.
|Earnings Date||Nov 1, 2023|
Innoviva has 64.09 million shares outstanding. The number of shares has decreased by -10.09% in one year.
|Shares Change (YoY)||-10.09%|
|Shares Change (QoQ)||+31.57%|
|Owned by Insiders (%)||1.34%|
|Owned by Institutions (%)||110.39%|
The trailing PE ratio is 19.01 and the forward PE ratio is 18.14. Innoviva's PEG ratio is 0.24.
The stock's EV/EBITDA ratio is 9.67, with an EV/FCF ratio of 9.82.
|EV / Earnings||22.92|
|EV / Sales||3.94|
|EV / EBITDA||9.67|
|EV / EBIT||13.38|
|EV / FCF||9.82|
The company has a current ratio of 8.43, with a Debt / Equity ratio of 0.71.
|Debt / Equity||0.71|
|Debt / EBITDA||3.77|
|Debt / FCF||3.83|
Return on equity (ROE) is 8.60% and return on invested capital (ROIC) is 6.38%.
|Return on Equity (ROE)||8.60%|
|Return on Assets (ROA)||4.30%|
|Return on Capital (ROIC)||6.38%|
|Revenue Per Employee||$2.88M|
|Profits Per Employee||$493,832|
In the past 12 months, Innoviva has paid $18.33 million in taxes.
|Effective Tax Rate||26.88%|
Stock Price Statistics
The stock price has increased by +6.29% in the last 52 weeks. The beta is 0.50, so Innoviva's price volatility has been lower than the market average.
|52-Week Price Change||+6.29%|
|50-Day Moving Average||13.23|
|200-Day Moving Average||12.65|
|Relative Strength Index (RSI)||56.08|
|Average Volume (30 Days)||692,515|
Short Selling Information
The latest short interest is 9.61 million, so 14.99% of the outstanding shares have been sold short.
|Short Previous Month||8.97M|
|Short % of Shares Out||14.99%|
|Short % of Float||18.40%|
|Short Ratio (days to cover)||12.81|
In the last 12 months, Innoviva had revenue of $290.43 million and earned $49.88 million in profits. Earnings per share was $0.72.
|Earnings Per Share (EPS)||$0.72|
The company has $180.00 million in cash and $445.72 million in debt, giving a net cash position of -$265.72 million or -$4.15 per share.
|Cash & Cash Equivalents||180.00M|
|Net Cash Per Share||-$4.15|
|Equity / Book Value||627.49M|
|Book Value Per Share||9.79|
In the last 12 months, operating cash flow was $116.71 million and capital expenditures -$294,000, giving a free cash flow of $116.41 million.
|Operating Cash Flow||116.71M|
|Free Cash Flow||116.41M|
|FCF Per Share||$1.79|
Gross margin is 86.36%, with operating and profit margins of 32.24% and 17.17%.
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for Innoviva is $15.17, which is 9.02% higher than the current price. The consensus rating is "Hold".
|Price Target Difference||9.02%|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on June 3, 2014. It was a forward split with a ratio of 1241:1000.
|Last Split Date||Jun 3, 2014|
Innoviva has an Altman Z-Score of 1.59 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.